---
layout: post
title: ADCY5
date: 2025-01-17 16:55 CST
description: ADCY5 description
tags: [cooccuring-genes]
categories: unknown-mechanism
pretty_table: true
citation: true
related_posts: true
---



| [NCBI ID](https://www.ncbi.nlm.nih.gov/gene/111) | NCBI symbol | ENSEMBL ID | Chromosome location |
| :-------- | :------- | :-------- | :------- |
| 111  | ADCY5 | ENSG00000173175 | 3q21.1 |



The gene is involved in the [G protein-coupled adenosine receptor signaling pathway](https://amigo.geneontology.org/amigo/term/GO:0001973) and the [cAMP biosynthetic process](https://amigo.geneontology.org/amigo/term/GO:0006171). It enables [adenylate cyclase activity](https://amigo.geneontology.org/amigo/term/GO:0004016) and [ATP binding](https://amigo.geneontology.org/amigo/term/GO:0005524), and is located in the [plasma membrane](https://amigo.geneontology.org/amigo/term/GO:0005886) and [cilium](https://amigo.geneontology.org/amigo/term/GO:0005929). Additionally, it is involved in various signaling pathways, including the [adenylate cyclase-activating G protein-coupled receptor signaling pathway](https://amigo.geneontology.org/amigo/term/GO:0007189), [adenylate cyclase-activating dopamine receptor signaling pathway](https://amigo.geneontology.org/amigo/term/GO:0007191), [adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway](https://amigo.geneontology.org/amigo/term/GO:0007193), and [adenylate cyclase-inhibiting dopamine receptor signaling pathway](https://amigo.geneontology.org/amigo/term/GO:0007195). The gene also plays a role in the [positive regulation of cytosolic calcium ion concentration](https://amigo.geneontology.org/amigo/term/GO:0007204), [locomotory behavior](https://amigo.geneontology.org/amigo/term/GO:0007626), [intracellular signal transduction](https://amigo.geneontology.org/amigo/term/GO:0035556), [neuromuscular process controlling balance](https://amigo.geneontology.org/amigo/term/GO:0050885), and [regulation of insulin secretion involved in cellular response to glucose stimulus](https://amigo.geneontology.org/amigo/term/GO:0061178). Furthermore, it enables [adenylate cyclase binding](https://amigo.geneontology.org/amigo/term/GO:0008179), [metal ion binding](https://amigo.geneontology.org/amigo/term/GO:0046872), and [scaffold protein binding](https://amigo.geneontology.org/amigo/term/GO:0097110), and is involved in the [cellular response to forskolin](https://amigo.geneontology.org/amigo/term/GO:1904322).


The gene length is 43,416 base pairs (62.49% of all genes), the mature length is 2,555 base pairs, and the primary transcript length is 43,416 base pairs.


The gene ADCY5 (NCBI ID: 111) has been mentioned in [74 publications](https://pubmed.ncbi.nlm.nih.gov/?term=%22ADCY5%22) according to [Pubtator](https://academic.oup.com/nar/article/47/W1/W587/5494727), with the earliest publication in 2002 and the middle 50% of publications occurring between 2015 and 2020. Note that the publication count in the hyperlink may be different since the count is from Pubtator.


The top five publications mentioning ADCY5, ranked by their scientific influence, include studies that explore various aspects of the gene's function and its association with different phenotypes. The [Relative Citation Ratio (RCR)](https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002541) measures the scientific influence of each paper by field- and time-adjusting the citations it has received, benchmarking to the median for NIH publications, which is set at 1.0. Notable publications include "[Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight.](https://pubmed.ncbi.nlm.nih.gov/20372150)" (2010) (relative citation ratio: 4.55), "[Phenotypic insights into ADCY5-associated disease.](https://pubmed.ncbi.nlm.nih.gov/27061943)" (2016) (relative citation ratio: 4.21), "[ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations.](https://pubmed.ncbi.nlm.nih.gov/26537056)" (2015) (relative citation ratio: 3.65), "[ADCY5 couples glucose to insulin secretion in human islets.](https://pubmed.ncbi.nlm.nih.gov/24740569)" (2014) (relative citation ratio: 3.34), and "[Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.](https://pubmed.ncbi.nlm.nih.gov/24700542)" (2014) (relative citation ratio: 3.17). Citation counts are sourced from [iCite](https://icite.od.nih.gov).


[ADCY5](https://www.proteinatlas.org/ENSG00000173175-ADCY5) is a gene encoding a protein with lyase molecular function. It is involved in intellectual disability, with evidence at the protein level. The gene is detected in many tissues and is particularly expressed in heart muscle, neurons, breast cancer cell lines, and smooth muscle cells. Subcellularly, the protein is localized to vesicles, the plasma membrane, and the primary cilium.


The top transcription factors (TFs) identified from GTRD's database of TF binding sites, based on the number of CHIP-seq experiments, include [KDM2B](https://www.ncbi.nlm.nih.gov/gene/84678) with 5 experiments, [ESR1](https://www.ncbi.nlm.nih.gov/gene/2099) with 4 experiments, [ZBTB7A](https://www.ncbi.nlm.nih.gov/gene/51341) with 4 experiments, [MYCN](https://www.ncbi.nlm.nih.gov/gene/4613) with 4 experiments, and [ERG](https://www.ncbi.nlm.nih.gov/gene/2078) with 4 experiments.



The GWAS data indicates associations with a range of disease conditions, including immune system disease, various metabolic disorders such as diabetes mellitus (particularly type 2 diabetes mellitus), obesity, and cardiovascular system disease. Additionally, the data highlights links to kidney disease, including chronic and end-stage renal failure, as well as nervous system diseases like cognitive disorders and neuropathy. Autoimmune diseases of the nervous system, such as myasthenia gravis, and hypersensitivity reactions are also implicated.



The gene is expressed in various tissues, including the heart, blood vessel, and esophagus, as indicated by the BioGPS Human Cell Type and Tissue Gene Expression Profiles. Additionally, the GTEx Tissue Gene Expression Profiles show expression in the Ciliary Ganglion, Globus Pallidus, and Ovary.


The input data highlights various biological pathways, including metabolism, transmembrane transport of small molecules, and multiple signaling pathways such as Hedgehog, DAP12, PDGF, FGFR, ERBB2, and EGFR. Additionally, it covers immune system processes, particularly the innate immune system, and various G-protein coupled receptor (GPCR) signaling events. The data also includes pathways related to energy metabolism, insulin secretion regulation, and neurotransmitter signaling, specifically involving GABA receptors and opioid signaling. Furthermore, it encompasses calcium-dependent events, calmodulin-induced events, and phospholipase C-mediated cascades.



The analyzed protein sequence has a GRAVY value of -0.033 (82.36th percentile), indicating a hydrophilic nature. The charge at pH 7.0 is -0.864 (47.21st percentile), and the median structural flexibility is 0.996 (24.97th percentile). The protein has a length of 1261 amino acids (92.7th percentile) and a molecular weight of 138906.09 Da (92.55th percentile). The secondary structure affinities are 33.0% for helix (59.26th percentile), 35.0% for sheet (58.97th percentile), and 26.9% for turn (37.0th percentile). The instability index is 44.01 (35.73rd percentile), and the isoelectric point is 6.90 (49.2nd percentile). For more details on the sequence analysis, refer to the [BioPython documentation](https://biopython.org/docs/1.75/api/Bio.SeqUtils.ProtParam.html).





| Checks    | Answer |
| :-------- | :------- |
| Sentiment  | neutral   |
| Ethical concerns | no     |
| Coherence    | no    |